Addex Therapeutics Ltd – NASDAQ:ADXN
Addex Therapeutics Ltd stock price today
Addex Therapeutics Ltd stock price monthly change
Addex Therapeutics Ltd stock price quarterly change
Addex Therapeutics Ltd stock price yearly change
Addex Therapeutics Ltd key metrics
Market Cap | 11.14M |
Enterprise value | N/A |
P/E | -0.35 |
EV/Sales | -3.01 |
EV/EBITDA | 0.17 |
Price/Sales | 4.80 |
Price/Book | 0.74 |
PEG ratio | -0.05 |
EPS | -0.13 |
Revenue | 1.34M |
EBITDA | -8.39M |
Income | -11.23M |
Revenue Q/Q | -53.10% |
Revenue Y/Y | -20.11% |
Profit margin | -1757.77% |
Oper. margin | -1735.01% |
Gross margin | 0% |
EBIT margin | -1735.01% |
EBITDA margin | -623.37% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAddex Therapeutics Ltd stock price history
Addex Therapeutics Ltd stock forecast
Addex Therapeutics Ltd financial statements
| Jun 2023 | 630.87K | -2.67M | -424.04% |
|---|---|---|---|
| Sep 2023 | 327.73K | -2.61M | -798.54% |
| Dec 2023 | 153.45K | -2.85M | -1861.73% |
| Mar 2024 | 234.91K | -3.08M | -1314.18% |
| 2027 | 6.56M | 0 |
|---|
Analysts Price target
Financials & Ratios estimates
| 2023-11-29 | -4 | -4.07 |
|---|
| Jun 2023 | 8998443 | 2.87M | 31.92% |
|---|---|---|---|
| Sep 2023 | 6138100 | 2.19M | 35.74% |
| Dec 2023 | 4641885 | 3.49M | 75.32% |
| Mar 2024 | 3333713 | 4.70M | 141.26% |
| Jun 2023 | -2.75M | -2.49K | 4.48M |
|---|---|---|---|
| Sep 2023 | -2.25M | -678 | -188.96K |
| Dec 2023 | -623.02K | -1.20K | -58.35K |
| Mar 2024 | -2.19M | 0 | 163.27K |
Addex Therapeutics Ltd alternative data
| Aug 2023 | 24 |
|---|---|
| Sep 2023 | 24 |
| Oct 2023 | 24 |
| Nov 2023 | 24 |
| Dec 2023 | 24 |
| Jan 2024 | 24 |
| Feb 2024 | 24 |
| Mar 2024 | 24 |
| Apr 2024 | 24 |
| May 2024 | 23 |
| Jun 2024 | 23 |
| Jul 2024 | 23 |
Addex Therapeutics Ltd other data
| Quarter | Transcript |
|---|---|
| Q1 2024 6 Jun 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 18 Apr 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 29 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Timothy Mark Dyer (1968) Co-Founder, Chief Executive Officer & Director | $627,200 |
-
What's the price of Addex Therapeutics Ltd stock today?
One share of Addex Therapeutics Ltd stock can currently be purchased for approximately $7.93.
-
When is Addex Therapeutics Ltd's next earnings date?
Unfortunately, Addex Therapeutics Ltd's (ADXN) next earnings date is currently unknown.
-
Does Addex Therapeutics Ltd pay dividends?
No, Addex Therapeutics Ltd does not pay dividends.
-
How much money does Addex Therapeutics Ltd make?
Addex Therapeutics Ltd has a market capitalization of 11.14M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13.39% to 1.61M US dollars. Addex Therapeutics Ltd made a loss 10.56M US dollars in net income (profit) last year or -$4.07 on an earnings per share basis.
-
What is Addex Therapeutics Ltd's stock symbol?
Addex Therapeutics Ltd is traded on the NASDAQ under the ticker symbol "ADXN".
-
What is Addex Therapeutics Ltd's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Addex Therapeutics Ltd?
Shares of Addex Therapeutics Ltd can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Addex Therapeutics Ltd's key executives?
Addex Therapeutics Ltd's management team includes the following people:
- Mr. Timothy Mark Dyer Co-Founder, Chief Executive Officer & Director(age: 57, pay: $627,200)
-
Is Addex Therapeutics Ltd founder-led company?
Yes, Addex Therapeutics Ltd is a company led by its founder Mr. Timothy Mark Dyer.
-
How many employees does Addex Therapeutics Ltd have?
As Jul 2024, Addex Therapeutics Ltd employs 23 workers, which is 4% less then previous quarter.
-
When Addex Therapeutics Ltd went public?
Addex Therapeutics Ltd is publicly traded company for more then 5 years since IPO on 12 Feb 2020.
-
What is Addex Therapeutics Ltd's official website?
The official website for Addex Therapeutics Ltd is addextherapeutics.com.
-
How can i contact Addex Therapeutics Ltd?
Addex Therapeutics Ltd can be reached via phone at +41 22 884 15 55.
Addex Therapeutics Ltd company profile:
Addex Therapeutics Ltd
addextherapeutics.comNASDAQ
23
Biotechnology
Healthcare
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.
Geneva, 1202
CIK: 0001574232
ISIN: US00654J2069
CUSIP: 00654J107
